Gyre Therapeutics Inc (GYRE)

Investing Cash Flow

$7.30M

TTM · Period ending: · USD

GYRE logo

GYRE Investing Cash Flow

Latest reported$7.30M
GYRE TTM Cash from Investing (-$250.25K → $7.30M)
High-resolution chart · PNG

GYRE investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Gyre Therapeutics Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
7,303,000
-5,496,000
-474,000
-4,326,000
-5,466,000
-10,697,000
-19,884,000
-16,541,000
-19,554,000
-19,332,000
-19,760,000
-90,288,000
-84,888,000
-23,966,000
-19,440,355
52,614,645
59,652,645
17,485,645
48,189,000
72,874,000
44,569,000
9,823,000
9,663,000
-17,448,000
18,447,000
46,150,000
27,392,000
31,107,000
12,841,000
-63,461,000
-71,321,000
-77,002,000
-89,850,000
-17,228,000
-11,252,000
-3,885,000
14,984,000
9,243,000
-1,308,000
3,826,000
-3,826,000
12,548,000
37,357,000
40,635,000
56,088,000
52,958,000
33,856,000
23,539,000
21,904,000
18,197,000
13,409,000
25,307,000
33,494,000
30,177,000
39,822,000
21,797,000
-13,938,000
-45,336,000
-57,667,000
-61,712,000
-62,754,000
-51,169,000
-62,799,000
-56,611,000
-36,600,000
-7,276,000
9,800,000
4,776,780
9,984,046
7,682,631
-5,519,000
1,121,009
-22,880,608
-38,971,416
-26,286,162
-28,177,326
-9,498,321
-13,685,519
-13,267,418
-12,958,487
-12,817,132
-323,002
-250,247
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.